Mass-transfer Biot number for drug release
ID: mass-transfer-biot-number-for-drug-release
The mass-transfer Biot number for drug releasecompares internal diffusive resistance with external mass-transfer resistance in a specified release model. Here is a receiving-side transfer coefficient, the chosen matrix transport length and the internal diffusion coefficient. Its value is dimensionless. The definition requires compatible concentration scales; interfacial partitioning must be included if the phases do not share one.
For the steady planar model in finite mass-transfer boundary in drug release,A large means external resistance is small relative to the specified internal resistance. A small means receiving-side transport can dominate. The comparison says nothing by itself about whether the bulk concentration is near zero, whether is constant or whether the chosen steady model applies.
The sink-boundary approximation error in drug release can be quantified in this model. With fixed , let be the negligible-external-resistance flux. ThenRequiring this last error to be no more than gives . If the error is instead divided by the actual finite-resistance flux , the ratio is and the corresponding threshold is . A numerical rule is incomplete without its denominator and model assumptions.
For an original example with , and , . The external-resistance-free approximation exceeds the model flux by relative to , or about relative to .
A release experiment can change receiving flow or membrane transport while keeping the formulation fixed. The FDA’s adaptive-perfusion account specifically contrasts passive dialysis-membrane diffusion with pressure-driven separation.[ref]
Adaptive Perfusion: A Novel In Vitro Drug Release Testing Method for Complex Drug Products by the FDA. Technology Summary, rate-limiting membrane diffusion and tangential flow filtration
Such observations motivate checking external resistance; a fitted release curve alone does not measure , and independently. New to topics? Read the docs here!